Groupe d'Etude en Oncologie du Quebec

Title	DOvEEgene: Developing and Validating a Novel Molecular Screening Test for the Early Diagnosis of Cancer of the Endometrium, Tubes and Ovaries
Protocole ID	A08-M79-13B
ClinicalTrials.gov ID	NCT02288676
Cancer Type(s)	Ovary
Phase	Other
Stage
Study Type	Diagnostic
Drug
Institution	CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN 1001 boul. Décarie , Montréal, QC, H4A 3J1
City	Montréal
Principal Investigator	Dr. Lucy Gilbert
Coordinator	Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975
Status	Recruiting
Activation Date
Eligibility Criteria	Case Inclusion: Subjects should have suspected or confirmed cancer of the upper genital tract. Participant will undergo surgery for tumour removal. Control inclusion: • Subjects should be scheduled to have a hysterectomy, bilateral salpingectomy, with or without bilateral oophorectomy, for presumed benign disease.
Exclusion Criteria

Groupe d'étude en oncologie du Québec